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Lung problems are common in allogeneic stem cell transplant (SCT) recipients. The aetiology is complex and includes infectious causes, immunological problems, pulmonary haemorrhage, adult respiratory distress syndrome (ARDS), and manifestation of malignant disease.
1,2 Many pulmonary complications in allogeneic SCT recipients can now be managed effectively, although mortality is still considerable. Some potential treatments are either expensive or have significant side-effects, rendering rapid aetiological diagnosis essential.
Bronchoalveolar lavage (BAL) is commonly used to reach an aetiological diagnosis in allogeneic SCT recipients with lung problems, [3] [4] [5] but sampling is susceptible to contamination from the upper airways. Open lung biopsy (OLB) [6] [7] [8] is an invasive procedure with potential complications. Although radiologically guided fine needle lung biopsy (FNLB) has been commonly used in other patient groups, [9] [10] [11] this method has rarely been applied in allogeneic SCT recipients. We have reviewed our recent experience on FNLB in the evaluation of focal pulmonary lesions in allogeneic SCT recipients.
Patients and methods
Between 1 January 1989 and 31 December 1998, 344 adult patients received an allogeneic SCT at the Department of Medicine, Helsinki University Central Hospital. From patient charts and the computerised procedure registry held at the Department of Radiology, Helsinki University Central Hospital, 21 patients (6% of all allotransplanted patients) were identified as having had radiologically guided FNLB after allogeneic SCT. Patient characteristics are summarised in Table 1 . 
Fine needle lung biopsies
FNLBs were taken by experienced radiologists under radiological guidance (ultrasound or computed tomography depending on the localization of the lesion) using a 20-22 G needle. One, or several needle aspirations of the lesion were taken. The specimen obtained was cultured for bacteria, fungi, and mycobacteria using standard methods. Conventional microscopy for fungi and staining for bacteria were also performed.
Data collection
Results of previous BAL studies performed Ͻ30 days before FNLB were collected from all patients. The platelet count on the day of FNLB was registered as was use of prophylactic platelet transfusions prior to the procedure. Possible complications of FNLB were evaluated in each case. A retrospective assessment was made on whether the results of FNLB changed patient management by triggering specific treatment or not. The final diagnosis of the lung problem in each patient incorporated the results of subsequent investigations (re-biopsy, BAL, OLB, autopsy).
Results

Procedures and complications
A total of 30 FNLBs was performed in 21 transplant recipients. The median time from SCT to the first FNLB was 131 days (20-343 days). The platelet count on the morning of the procedure ranged from 20 × 10 9 /l to 237 × 10 9 /l. If the platelet count was Ͻ80 × 10 9 /l, prophylactic platelet transfusions were given (8-20 units, median 8 units). In 17 procedures, FNLB was guided by ultrasound and in 13 cases by computed tomography.
Radiologically verified pneumothorax was observed after four procedures (13%). Drainage was not needed for treatment in any of the cases. In one procedure (3%), a selflimiting haemoptysis occurred.
Diagnostic yield and impact on treatment
BAL had been performed in 15 patients (74%) 0-27 days (median 3 days) before the first FNLB. In eight cases the findings were non-contributory. In four patients CMV, Pneumocystis carinii, Mycobacterium malmoensis and Xanthomonas were found (one of each). In three patients, a suggestion of IPA was raised based on BAL (0-3 days before FNLB).
The first FNLB yielded positive findings in seven patients (33%), most commonly suggesting invasive pulmonary aspergillosis (IPA) ( Table 2 ). In patients who had negative results on their first FNLB, several additional procedures were performed (Table 3) . IPA was the most common final diagnosis, in this group, but also immunological lung problems, subsequently successfully treated with corticosteroids, were found in some patients.
Diagnostic findings from FNLB (first or subsequent) affected patient management on eight occasions (27%). Amphotericin B was started immediately after FNLB in five cases. In addition, the finding of Pseudomonas and Nocardia from FNLB led to changes in antimicrobial treatment in three patients. Final diagnosis of the lung problem was IPA in 14 patients, immunological lung problems in four patients, and other causes in three patients.
Median survival from the first FNLB was 92 days (2-2894 days). Up to October 2001, 17 patients (81%) have died. Eleven patients (65%) were autopsied. The most common causes of death were IA (nine patients) followed by IA plus GVHD (three patients) and relapse (two patients).
Discussion
Allogeneic SCT recipients with pulmonary problems constitute a common and challenging clinical problem. Several possible aetiologies exist and, in addition, the same patient may have several simultaneous causes. Diagnostic algorithms have been proposed to evaluate immunocompromised patients with lung problems.
12,13 BAL has commonly been used in these patients to reach a diagnosis, sometimes followed by OLB. This retrospective analysis indicates that radiologically guided FNLB is also feasible in this patient population and carries a low risk of complications and a relatively high diagnostic yield.
Much experience exists in bronchoalveolar lavage in allogeneic SCT recipients. BAL may yield useful diagnostic information in allogeneic SCT recipients with regard to, for example, cytomegalovirus, 14, 15 Pneumocystis, 16 Toxoplasma, 17 Aspergillus, 18, 19 and Mycobacteria. All these findings are clinically useful and may influence patient management. Therefore, BAL is a logical way to start in allogeneic SCT recipients with diffuse pulmonary lesions and has also been the method of choice in our unit. However, BAL is often negative or inconclusive and in these cases some type of biopsy should be considered, particularly if the patient does not improve quickly with empirical therapy.
Open lung biopsy has the advantage of yielding a high percentage of specific diagnoses. 7, 8, 20 However, OLB is an invasive procedure and is associated with significant morbidity and even mortality. Therefore, radiologically guided FNLB might be preferred in some patients with focal pulmonary lesions after SCT. Although FNLB has been commonly used in other transplant recipients, 21, 22 limited information is available on the feasibility and diagnostic yield of FNLB in the allogeneic SCT setting. In addition to the present report, we have found only one previous series of FNLB in SCT recipients. 23 The present analysis revealed that FNLB is feasible in this patient population. No major complications occurred. Thirteen per cent of the patients experienced an asymptomatic pneumothorax and one patient (3%) a minor haemoptysis. Crawford et al 23 reported an equal incidence (15%) for complications after FNLB. Their material included one massive haemoptysis requiring tracheal intubation and two cases with pneumothorax (one requiring tube thoracostomy). Thus, the complication rate of FNLB seems to be much lower when compared to larger cutting needle lung biopsies. 24 Our analysis suggests that bleeding complications are rare in allogeneic SCT recipients, provided that adequate platelet support is used.
The diagnostic yield of FNLB was quite high in the present analysis, but is apparently dependent on the type of lesions selected for this approach. Findings suggesting invasive pulmonary aspergillosis were the most common. However, the first FNLB gave findings suggestive of IPA in only five patients, and in two other patients a subsequent FNLB was suggestive of IPA. Altogether, 14 patients in this series had invasive aspergillosis diagnosed either on biopsy or autopsy. This suggests that while FNLB is useful Bone Marrow Transplantation in diagnosing IPA, negative findings are of limited value. An additional benefit of FNLB with regard to fungal infections is rapidity of diagnosis. The results of conventional microscopy are usually available on the same day.
Other diagnostically useful findings of FNLB in the present series included Pseudomonas and Nocardia. Other diseases diagnosed with FNLB include tuberculosis, 25 posttransplant lymphoproliferative disease, 22 and relapse of the underlying haematologic disease. Two of our patients had mycobacterial infection (M. malmoensis, M. fortuitum) diagnosed with BAL before FNLB. They were both receiving antimycobacterial treatment, and FNLB showed no signs of acid-fast basilli in either patient.
To conclude, radiologically guided FNLB is feasible and relatively safe in the evaluation of focal pulmonary lesions in allogeneic SCT recipients. The diagnostic yield is high, particularly for invasive pulmonary aspergillosis.
